A retrospective study on pathologic features and racial disparities in prostate cancer
- PMID: 22135747
- PMCID: PMC3206508
- DOI: 10.1155/2011/239460
A retrospective study on pathologic features and racial disparities in prostate cancer
Abstract
We reviewed more than 3,000 pathology reports on prostate cancer-related surgical specimens and analyzed racial disparities in histological and clinical features at the time of initial biopsy, diagnosis of prostate cancer, and prostatectomy, as well as in characteristics of tumor evolution between African American and Caucasian patients. As compared to Caucasians, African American patients had younger age, higher cancer detection rate, higher Gleason score of prostate cancer, and more bilateral involvement of the prostate. African Americans also had larger prostates, greater volume of tumor, and more positive margins. The diagnosis of HGPIN or ASAP in prostate biopsies and African American race conferred an increased risk of diagnosis of prostate cancer. The interval between prior noncancerous biopsy and the subsequent biopsy with diagnosis of prostate cancer was shorter in men with HGPIN, with ASAP, or of African American race.
Figures
Similar articles
-
Prostate cancer detection rate and the importance of premalignant lesion in rebiopsy.Med Arh. 2011;65(2):109-12. Med Arh. 2011. PMID: 21585187
-
Initial high-grade prostatic intraepithelial neoplasia with carcinoma on subsequent prostate needle biopsy: findings at radical prostatectomy.Am J Surg Pathol. 2011 Aug;35(8):1165-7. doi: 10.1097/PAS.0b013e3182206da8. Am J Surg Pathol. 2011. PMID: 21716083 Free PMC article.
-
Atypical small acinar proliferation (ASAP) on extended prostatic biopsies: predictive factors of cancer detection on repeat biopsies.Arch Ital Urol Androl. 2005 Mar;77(1):31-6. Arch Ital Urol Androl. 2005. PMID: 15906787
-
Atypical small acinar proliferation (ASAP): Is a repeat biopsy necessary ASAP? A multi-institutional review.Prostate Cancer Prostatic Dis. 2016 Mar;19(1):68-71. doi: 10.1038/pcan.2015.52. Epub 2015 Nov 17. Prostate Cancer Prostatic Dis. 2016. PMID: 26857145 Review.
-
Racial Differences in Prostate Cancer Characteristics and Cancer-Specific Mortality: An Overview.World J Mens Health. 2022 Apr;40(2):217-227. doi: 10.5534/wjmh.210070. Epub 2022 Jan 1. World J Mens Health. 2022. PMID: 35021294 Free PMC article. Review.
Cited by
-
Incidence trends in prostate cancer among men in the United States from 2000 to 2020 by race and ethnicity, age and tumor stage.Front Oncol. 2023 Nov 30;13:1292577. doi: 10.3389/fonc.2023.1292577. eCollection 2023. Front Oncol. 2023. PMID: 38098506 Free PMC article.
-
Vitamin D and Immune Response: Implications for Prostate Cancer in African Americans.Front Immunol. 2016 Feb 22;7:53. doi: 10.3389/fimmu.2016.00053. eCollection 2016. Front Immunol. 2016. PMID: 26941739 Free PMC article. Review.
-
Associating serum testosterone levels with African ancestral prostate cancer health disparities.Sci Rep. 2025 Apr 8;15(1):12013. doi: 10.1038/s41598-025-92539-y. Sci Rep. 2025. PMID: 40199972 Free PMC article.
-
Clinical Outcomes and Racial Disparities in Metastatic Hormone-Sensitive Prostate Cancer in the Era of Novel Treatment Options.Oncologist. 2021 Nov;26(11):956-964. doi: 10.1002/onco.13848. Epub 2021 Jun 29. Oncologist. 2021. PMID: 34096667 Free PMC article.
-
Nuclear MTA1 overexpression is associated with aggressive prostate cancer, recurrence and metastasis in African Americans.Sci Rep. 2013;3:2331. doi: 10.1038/srep02331. Sci Rep. 2013. PMID: 23900262 Free PMC article.
References
-
- Ries LAG, Melbert D, Krapcho M, et al. SEER cancer statistics review, 1975–2005. National Cancer Institute, 2008, http://www.seer.cancer.gov/csr/1975_2005/
-
- Smith DS, Carvalhal GF, Mager DE, Bullock AD, Catalona WJ. Use of lower prostate specific antigen cutoffs for prostate cancer screening in black and white men. Journal of Urology. 1998;160(5):1734–1738. - PubMed
-
- Fowler JE, Bigler SA, Farabaugh PB. Prospective study of cancer detection in black and white men with normal digital rectal examination but prostate specific antigen equal or greater than 4.0 ng/mL. Cancer. 2002;94(6):1661–1667. - PubMed
-
- Latchamsetty KC, Kim J, Porter CR. Prostate specific antigen remains an independent predictor of cancer at prostate biopsy in black American men but not in white men: results from a consecutive series of 914 men. Journal of Urology. 2006;175(3):913–917. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials